Blood Test for Alzheimer's Disease - Global Top Players Market Share and Ranking 2026- YH Research

日本语 | 中文

Home > Reports >Medical Care > Blood Test for Alzheimer's Disease - Global Top Players Market Share and Ranking 2026

Blood Test for Alzheimer's Disease - Global Top Players Market Share and Ranking 2026

Publication Date: 2026-07-05
Report Id: 3135531
Industry: Medical Care
Report Page: 115
Chart: 116

PDF Download

Publication Date: 2026-07-05
Report Id: 3135531
Industry: Medical Care
Report Page: 115
Chart: 116

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Blood Test for Alzheimer's Disease Definition
1.2 Global Blood Test for Alzheimer's Disease Market Size and Forecast
1.3 Japan Blood Test for Alzheimer's Disease Market Size and Forecast
1.4 Share of Japan Blood Test for Alzheimer's Disease Market with Respect to the Global Market
1.5 Blood Test for Alzheimer's Disease Market Size: Japan VS Global Growth Rate, 2021-2032
1.6 Blood Test for Alzheimer's Disease Market Dynamics
1.6.1 Blood Test for Alzheimer's Disease Market Drivers
1.6.2 Blood Test for Alzheimer's Disease Market Restraints
1.6.3 Blood Test for Alzheimer's Disease Industry Trends
1.6.4 Blood Test for Alzheimer's Disease Industry Policy

2 Global Leading Players and Market Share
2.1 By Revenue of Blood Test for Alzheimer's Disease, Global Market Share by Company, 2021-2026
2.2 Global Blood Test for Alzheimer's Disease Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Blood Test for Alzheimer's Disease Concentration Ratio
2.4 Global Blood Test for Alzheimer's Disease Mergers & Acquisitions, Expansion Plans
2.5 Global Blood Test for Alzheimer's Disease Major Companies Product Type
2.6 Head Office and Area Served of Key Players

3 Japan Leading Players, Market Share and Ranking
3.1 By Revenue of Blood Test for Alzheimer's Disease, Japan Market Share by Company, 2021-2026
3.2 Japan Blood Test for Alzheimer's Disease Blood Test for Alzheimer's Disease Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Industry Chain Analysis
4.1 Blood Test for Alzheimer's Disease Industry Chain
4.2 Blood Test for Alzheimer's Disease Upstream Analysis
4.2.1 Blood Test for Alzheimer's Disease Core Raw Materials
4.2.2 Main Manufacturers of Blood Test for Alzheimer's Disease Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Blood Test for Alzheimer's Disease Production Mode
4.6 Blood Test for Alzheimer's Disease Procurement Model
4.7 Blood Test for Alzheimer's Disease Industry Sales Model and Sales Channels
4.7.1 Blood Test for Alzheimer's Disease Sales Model
4.7.2 Blood Test for Alzheimer's Disease Typical Distributors

5 Sights Blood Test for Alzheimer's Disease Market Classification
5.1 Blood Test for Alzheimer's Disease Classification by Type
5.1.1 Chemiluminescence Immunoassay
5.1.2 Single-molecule and Other
5.1.3 Others
5.1.4 by Type, Global Blood Test for Alzheimer's Disease Consumption Value & CAGR, 2021 VS 2025 VS 2032
5.1.5 by Type, Global Blood Test for Alzheimer's Disease Consumption Value, 2021-2032
5.2 Blood Test for Alzheimer's Disease Classification by Testing Markers
5.2.1 Single Biomarker Tests
5.2.2 Multi-Biomarker Panel Tests
5.2.3 Others
5.2.4 by Testing Markers, Global Blood Test for Alzheimer's Disease Consumption Value & CAGR, 2021 VS 2025 VS 2032
5.2.5 by Testing Markers, Global Blood Test for Alzheimer's Disease Consumption Value, 2021-2032
5.3 Blood Test for Alzheimer's Disease Classification by Commercialization Status
5.3.1 Commercialized Products
5.3.2 Products under Development or Registration
5.3.3 Research Use Only Products
5.3.4 by Commercialization Status, Global Blood Test for Alzheimer's Disease Consumption Value & CAGR, 2021 VS 2025 VS 2032
5.3.5 by Commercialization Status, Global Blood Test for Alzheimer's Disease Consumption Value, 2021-2032

6 Sights by Application
6.1 Blood Test for Alzheimer's Disease Segment by Application
6.1.1 Clinical
6.1.2 Non-clinical
6.2 by Application, Global Blood Test for Alzheimer's Disease Consumption Value & CAGR, 2021 VS 2025 VS 2032
6.3 by Application, Global Blood Test for Alzheimer's Disease Consumption Value, 2021-2032

7 Sales Sights by Region
7.1 By Region, Global Blood Test for Alzheimer's Disease Consumption Value, 2021 VS 2025 VS 2032
7.2 By Region, Global Blood Test for Alzheimer's Disease Consumption Value, 2021-2032
7.3 North America
7.3.1 North America Blood Test for Alzheimer's Disease Market Size & Forecasts, 2021-2032
7.3.2 By Country, North America Blood Test for Alzheimer's Disease Market Size Market Share
7.4 Europe
7.4.1 Europe Blood Test for Alzheimer's Disease Market Size & Forecasts, 2021-2032
7.4.2 By Country, Europe Blood Test for Alzheimer's Disease Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Blood Test for Alzheimer's Disease Market Size & Forecasts, 2021-2032
7.5.2 By Country/Region, Asia Pacific Blood Test for Alzheimer's Disease Market Size Market Share
7.6 South America
7.6.1 South AmericaBlood Test for Alzheimer's Disease Market Size & Forecasts, 2021-2032
7.6.2 By Country, South America Blood Test for Alzheimer's Disease Market Size Market Share
7.7 Middle East & Africa

8 Sales Sights by Country Level
8.1 By Country, Global Blood Test for Alzheimer's Disease Market Size & CAGR, 2021 VS 2025 VS 2032
8.2 By Country, Global Blood Test for Alzheimer's Disease Consumption Value, 2021-2032
8.3 United States
8.3.1 United States Blood Test for Alzheimer's Disease Market Size, 2021-2032
8.3.2 by Type, United States Blood Test for Alzheimer's Disease Consumption Value Market Share, 2025 VS 2032
8.3.3 by Application, United States Blood Test for Alzheimer's Disease Consumption Value Market Share, 2025 VS 2032
8.4 Europe
8.4.1 Europe Blood Test for Alzheimer's Disease Market Size, 2021-2032
8.4.2 by Type, Europe Blood Test for Alzheimer's Disease Consumption Value Market Share, 2025 VS 2032
8.4.3 by Application, Europe Blood Test for Alzheimer's Disease Consumption Value Market Share, 2025 VS 2032
8.5 China
8.5.1 China Blood Test for Alzheimer's Disease Market Size, 2021-2032
8.5.2 by Type, China Blood Test for Alzheimer's Disease Consumption Value Market Share, 2025 VS 2032
8.5.3 by Application, China Blood Test for Alzheimer's Disease Consumption Value Market Share, 2025 VS 2032
8.6 Japan
8.6.1 Japan Blood Test for Alzheimer's Disease Market Size, 2021-2032
8.6.2 by Type, Japan Blood Test for Alzheimer's Disease Consumption Value Market Share, 2025 VS 2032
8.6.3 by Application, Japan Blood Test for Alzheimer's Disease Consumption Value Market Share, 2025 VS 2032
8.7 South Korea
8.7.1 South Korea Blood Test for Alzheimer's Disease Market Size, 2021-2032
8.7.2 by Type, South Korea Blood Test for Alzheimer's Disease Consumption Value Market Share, 2025 VS 2032
8.7.3 by Application, South Korea Blood Test for Alzheimer's Disease Consumption Value Market Share, 2025 VS 2032
8.8 Southeast Asia
8.8.1 Southeast Asia Blood Test for Alzheimer's Disease Market Size, 2021-2032
8.8.2 by Type, Southeast Asia Blood Test for Alzheimer's Disease Consumption Value Market Share, 2025 VS 2032
8.8.3 by Application, Southeast Asia Blood Test for Alzheimer's Disease Consumption Value Market Share, 2025 VS 2032
8.9 India
8.9.1 India Blood Test for Alzheimer's Disease Market Size, 2021-2032
8.9.2 by Type, India Blood Test for Alzheimer's Disease Consumption Value Market Share, 2025 VS 2032
8.9.3 by Application, India Blood Test for Alzheimer's Disease Consumption Value Market Share, 2025 VS 2032
8.10 Middle East & Africa
8.10.1 Middle East & Africa Blood Test for Alzheimer's Disease Market Size, 2021-2032
8.10.2 by Type, Middle East & Africa Blood Test for Alzheimer's Disease Consumption Value Market Share, 2025 VS 2032
8.10.3 by Application, Middle East & Africa Blood Test for Alzheimer's Disease Consumption Value Market Share, 2025 VS 2032

9 Company Profile
9.1 Quanterix
9.1.1 Quanterix Company Information, Head Office, Market Area, and Industry Position
9.1.2 Quanterix Company Profile and Main Business
9.1.3 Quanterix Blood Test for Alzheimer's Disease Models, Specifications, and Application
9.1.4 Quanterix Blood Test for Alzheimer's Disease Revenue and Gross Margin, 2021-2026
9.1.5 Quanterix Recent Developments
9.2 Sysmex
9.2.1 Sysmex Company Information, Head Office, Market Area, and Industry Position
9.2.2 Sysmex Company Profile and Main Business
9.2.3 Sysmex Blood Test for Alzheimer's Disease Models, Specifications, and Application
9.2.4 Sysmex Blood Test for Alzheimer's Disease Revenue and Gross Margin, 2021-2026
9.2.5 Sysmex Recent Developments
9.3 Fujirebio
9.3.1 Fujirebio Company Information, Head Office, Market Area, and Industry Position
9.3.2 Fujirebio Company Profile and Main Business
9.3.3 Fujirebio Blood Test for Alzheimer's Disease Models, Specifications, and Application
9.3.4 Fujirebio Blood Test for Alzheimer's Disease Revenue and Gross Margin, 2021-2026
9.3.5 Fujirebio Recent Developments
9.4 Vazyme
9.4.1 Vazyme Company Information, Head Office, Market Area, and Industry Position
9.4.2 Vazyme Company Profile and Main Business
9.4.3 Vazyme Blood Test for Alzheimer's Disease Models, Specifications, and Application
9.4.4 Vazyme Blood Test for Alzheimer's Disease Revenue and Gross Margin, 2021-2026
9.4.5 Vazyme Recent Developments
9.5 Meso Scale Discovery
9.5.1 Meso Scale Discovery Company Information, Head Office, Market Area, and Industry Position
9.5.2 Meso Scale Discovery Company Profile and Main Business
9.5.3 Meso Scale Discovery Blood Test for Alzheimer's Disease Models, Specifications, and Application
9.5.4 Meso Scale Discovery Blood Test for Alzheimer's Disease Revenue and Gross Margin, 2021-2026
9.5.5 Meso Scale Discovery Recent Developments
9.6 Alamar Biosciences
9.6.1 Alamar Biosciences Company Information, Head Office, Market Area, and Industry Position
9.6.2 Alamar Biosciences Company Profile and Main Business
9.6.3 Alamar Biosciences Blood Test for Alzheimer's Disease Models, Specifications, and Application
9.6.4 Alamar Biosciences Blood Test for Alzheimer's Disease Revenue and Gross Margin, 2021-2026
9.6.5 Alamar Biosciences Recent Developments
9.7 Hoyotek
9.7.1 Hoyotek Company Information, Head Office, Market Area, and Industry Position
9.7.2 Hoyotek Company Profile and Main Business
9.7.3 Hoyotek Blood Test for Alzheimer's Disease Models, Specifications, and Application
9.7.4 Hoyotek Blood Test for Alzheimer's Disease Revenue and Gross Margin, 2021-2026
9.7.5 Hoyotek Recent Developments
9.8 PeopleBio
9.8.1 PeopleBio Company Information, Head Office, Market Area, and Industry Position
9.8.2 PeopleBio Company Profile and Main Business
9.8.3 PeopleBio Blood Test for Alzheimer's Disease Models, Specifications, and Application
9.8.4 PeopleBio Blood Test for Alzheimer's Disease Revenue and Gross Margin, 2021-2026
9.8.5 PeopleBio Recent Developments
9.9 Yonghe-sun
9.9.1 Yonghe-sun Company Information, Head Office, Market Area, and Industry Position
9.9.2 Yonghe-sun Company Profile and Main Business
9.9.3 Yonghe-sun Blood Test for Alzheimer's Disease Models, Specifications, and Application
9.9.4 Yonghe-sun Blood Test for Alzheimer's Disease Revenue and Gross Margin, 2021-2026
9.9.5 Yonghe-sun Recent Developments
9.10 MagQu
9.10.1 MagQu Company Information, Head Office, Market Area, and Industry Position
9.10.2 MagQu Company Profile and Main Business
9.10.3 MagQu Blood Test for Alzheimer's Disease Models, Specifications, and Application
9.10.4 MagQu Blood Test for Alzheimer's Disease Revenue and Gross Margin, 2021-2026
9.10.5 MagQu Recent Developments
9.11 Beckman Coulter Diagnostics
9.11.1 Beckman Coulter Diagnostics Company Information, Head Office, Market Area, and Industry Position
9.11.2 Beckman Coulter Diagnostics Company Profile and Main Business
9.11.3 Beckman Coulter Diagnostics Blood Test for Alzheimer's Disease Models, Specifications, and Application
9.11.4 Beckman Coulter Diagnostics Blood Test for Alzheimer's Disease Revenue and Gross Margin, 2021-2026
9.11.5 Beckman Coulter Diagnostics Recent Developments
9.12 Lychix
9.12.1 Lychix Company Information, Head Office, Market Area, and Industry Position
9.12.2 Lychix Company Profile and Main Business
9.12.3 Lychix Blood Test for Alzheimer's Disease Models, Specifications, and Application
9.12.4 Lychix Blood Test for Alzheimer's Disease Revenue and Gross Margin, 2021-2026
9.12.5 Lychix Recent Developments
9.13 Roche
9.13.1 Roche Company Information, Head Office, Market Area, and Industry Position
9.13.2 Roche Company Profile and Main Business
9.13.3 Roche Blood Test for Alzheimer's Disease Models, Specifications, and Application
9.13.4 Roche Blood Test for Alzheimer's Disease Revenue and Gross Margin, 2021-2026
9.13.5 Roche Recent Developments
9.14 Shenzhen Anqun
9.14.1 Shenzhen Anqun Company Information, Head Office, Market Area, and Industry Position
9.14.2 Shenzhen Anqun Company Profile and Main Business
9.14.3 Shenzhen Anqun Blood Test for Alzheimer's Disease Models, Specifications, and Application
9.14.4 Shenzhen Anqun Blood Test for Alzheimer's Disease Revenue and Gross Margin, 2021-2026
9.14.5 Shenzhen Anqun Recent Developments
9.15 Spear Bio
9.15.1 Spear Bio Company Information, Head Office, Market Area, and Industry Position
9.15.2 Spear Bio Company Profile and Main Business
9.15.3 Spear Bio Blood Test for Alzheimer's Disease Models, Specifications, and Application
9.15.4 Spear Bio Blood Test for Alzheimer's Disease Revenue and Gross Margin, 2021-2026
9.15.5 Spear Bio Recent Developments
9.16 Suzhou Astrabio
9.16.1 Suzhou Astrabio Company Information, Head Office, Market Area, and Industry Position
9.16.2 Suzhou Astrabio Company Profile and Main Business
9.16.3 Suzhou Astrabio Blood Test for Alzheimer's Disease Models, Specifications, and Application
9.16.4 Suzhou Astrabio Blood Test for Alzheimer's Disease Revenue and Gross Margin, 2021-2026
9.16.5 Suzhou Astrabio Recent Developments

10 Conclusion

11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer

According to YH Research, the global market for Blood Test for Alzheimer's Disease should grow from US$ 37.88 million in 2025 to US$ 275 million by 2032, with a CAGR of 29.2% for the period of 2026-2032.

Blood Test for Alzheimer's Disease refers to an in vitro diagnostic method that uses peripheral blood samples to measure neurodegenerative disease biomarkers associated with Alzheimer's disease-related pathological changes, in order to support the assessment of possible amyloid deposition, Tau pathology or related neuronal injury. Key biomarkers commonly include phosphorylated Tau proteins, beta-amyloid-related ratios, GFAP and NfL, and the test can be used for early screening, diagnostic support, triage management and pre-treatment assessment in patients with cognitive impairment. This type of test should not generally be regarded as the sole basis for confirming Alzheimer's disease, but should be interpreted together with clinical symptoms, cognitive assessment, imaging results or other laboratory findings. The market scope defined in this report refers to the reagent product market for blood-based Alzheimer's disease diagnostics, mainly measured by product sales revenue of reagent manufacturers or brand owners, and does not directly include testing service fees charged by hospitals, third-party clinical laboratories or central laboratories to patients, pharmaceutical companies or research programs.

Blood Test for Alzheimer's Disease

According to YH Research, the global market for Blood Test for Alzheimer's Disease should grow from US$ 37.88 million in 2025 to US$ 275 million by 2032, with a CAGR of 29.2% for the period of 2026-2032.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

The Blood Test for Alzheimer's Disease market is moving from research validation toward accelerated clinical adoption, driven by increasing demand for early screening, diagnostic support, patient stratification and pre-treatment assessment in cognitive impairment care. Compared with cerebrospinal fluid testing and PET imaging, blood-based diagnostics offer clear advantages in sample accessibility, patient acceptance, testing availability and cost efficiency, making them a promising front-end screening and triage tool in the Alzheimer's disease diagnostic pathway. Under the scope of this report, the market does not refer to the overall end-market value of testing services, but specifically to reagent product revenue related to blood-based Alzheimer's disease diagnostics, including clinically registered assays, research-use testing reagents, calibrators, quality controls and necessary consumables. Future competition will mainly focus on core biomarker selection, analytical sensitivity, quality of clinical validation, platform compatibility, regulatory progress and commercialization channels.

This report studies and analyses global Blood Test for Alzheimer's Disease status and future trends, to help determine the Blood Test for Alzheimer's Disease market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Blood Test for Alzheimer's Disease, and provides market size (US$ million) and Year-over-Year growth, considering 2025 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Blood Test for Alzheimer's Disease market size, history data 2021-2025, and forecast data 2026 -2032, (US$ million)
(2) Global Blood Test for Alzheimer's Disease by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(3) Japan Blood Test for Alzheimer's Disease by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(4) Global Blood Test for Alzheimer's Disease key consuming regions, consumption value and demand structure
(5) Blood Test for Alzheimer's Disease industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    Quanterix
    Sysmex
    Fujirebio
    Vazyme
    Meso Scale Discovery
    Alamar Biosciences
    Hoyotek
    PeopleBio
    Yonghe-sun
    MagQu
    Beckman Coulter Diagnostics
    Lychix
    Roche
    Shenzhen Anqun
    Spear Bio
    Suzhou Astrabio

Market segment by Type, covers
    Chemiluminescence Immunoassay
    Single-molecule and Other
    Others

Market segment by Testing Markers, covers
    Single Biomarker Tests
    Multi-Biomarker Panel Tests
    Others

Market segment by Commercialization Status, covers
    Commercialized Products
    Products under Development or Registration
    Research Use Only Products

Market segment by Application, can be divided into
    Clinical
    Non-clinical

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Blood Test for Alzheimer's Disease product scope, global consumption value, Japan consumption value, development opportunities, challenges, trends, and policies
Chapter 2: Global Blood Test for Alzheimer's Disease market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 3: Japan Blood Test for Alzheimer's Disease market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 4: Blood Test for Alzheimer's Disease industry chain, upstream, medium-stream, and downstream
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2021-2032
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2021-2032
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2021-2032
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2021-2032
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin
Chapter 10: Conclusions